Parental Concerns on Short Stature: A 15-Year Follow-Up
- PMID: 32037150
- PMCID: PMC7186152
- DOI: 10.1016/j.jpeds.2020.01.010
Parental Concerns on Short Stature: A 15-Year Follow-Up
Abstract
Objectives: To compare parental attitudes about short stature over time and determine possible factors that predict changes in attitudes.
Study design: At baseline (1993-1994), we surveyed parents about their attitudes regarding their children's height. We compared parents of children (aged 4-15 years) referred to endocrinologists (referred, 154) with those of children with heights <10th percentile seen by pediatricians during regular visits (control, 240). At follow-up (2008-2009), 103 control and 98 referred parents completed a similar survey. We then made a logistic regression analysis to observe changes in perception. Primary variables included self-esteem, treatment by peers, and ability to cope with current height.
Results: At baseline, referred parents perceived a worse impact of short stature on their children than did controls. At follow-up, instead, referred parents were 3.8 times more likely to report improvement in self-esteem, 2.4 times more likely to report improved treatment from peers, and 5.7 times more likely to report overall ability to cope with height than were unreferred parents. Perception of psychosocial improvement was greater in the referred than the control group. Referral was a stronger predictor of an improved follow-up response than patients' current height or change in height.
Conclusions: While incorporating parental attitudes into management decisions, clinicians should be aware that parental perceptions may change over time and that referral itself may lead parents to perceive psychosocial improvements over time.
Keywords: ethics; growth hormone; short stature.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



References
-
- Maheshwari N, Uli NK, Narasimhan S, Cuttler L. Idiopathic Short Stature: Decision Making in Growth Hormone Use. Indian J Pediatr. 2012; 79:238–243. - PubMed
-
- Cuttler L, Marinova D, Mercer MB, Connors A, Meehan R, Silvers JB. Patient, physician, and consumer drivers: referrals for short stature and access to specialty drugs. Med Care 2009;47:858–65. - PubMed
-
- Silvers JB, Marinova D, Mercer MB, Connors A, Cuttler L. A national study of physician recommendations to initiate and discontinue growth hormone for short stature. Pediatrics. 2010;126:468–76. - PubMed
-
- Finkelstein BS, Singh J, Silvers JB, Marrero U, Neuhauser D, Cuttler L. Patient Attitudes and Preferences regarding Treatment: GH Therapy for Childhood Short Stature. Hormone Research 1999; 51: 67–72. - PubMed
-
- Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB et al. Murad on behalf of the Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Reseas Paediatr 2016; 86:361–397. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical